Blockchain Registration Transaction Record
New Nose-to-Brain Tech Breaks Blood-Brain Barrier to Treat Alzheimer's
Oncotelic Therapeutics' nose-to-brain delivery system breaks the blood-brain barrier, targeting Alzheimer's and biodefense. Learn how this innovation reshapes CNS medicine.
This matters because the blood-brain barrier has been a major obstacle in treating Alzheimer's, brain tumors, and biodefense threats. Oncotelic's intranasal delivery platform could unlock effective therapies for millions of patients, potentially reducing the burden of neurodegenerative diseases and enhancing national security against bioweapons. It represents a shift from drug discovery to delivery innovation, offering hope where traditional approaches have failed.
| Blockchain | Details |
|---|---|
| Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
| Transaction ID | 0x97e68c09c61ec9767068a7eba452e67f8253b47b5dfd5c8ea41cd3c106e73849 |
| Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
| Chain | polygon-main |
| NewsRamp Digital Fingerprint | bake3__s-e7d4968365408fb488430131ebf980a1 |